These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 24467591)

  • 1. Selective cyclooxygenase inhibitors: current status.
    Nandakishore R; Yalavarthi PR; Kiran YR; Rajapranathi M
    Curr Drug Discov Technol; 2014 Jun; 11(2):127-32. PubMed ID: 24467591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-inflammatory drugs in the 21st century.
    Rainsford KD
    Subcell Biochem; 2007; 42():3-27. PubMed ID: 17612044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual acting anti-inflammatory drugs: a reappraisal.
    Bertolini A; Ottani A; Sandrini M
    Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The metabolic effects of inhibitors of 5-lipoxygenase and of cyclooxygenase 1 and 2 are an advancement in the efficacy and safety of anti-inflammatory therapy.
    Celotti F; Durand T
    Prostaglandins Other Lipid Mediat; 2003 Jul; 71(3-4):147-62. PubMed ID: 14518558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Druggable Prostanoid Pathway.
    Mazaleuskaya LL; Ricciotti E
    Adv Exp Med Biol; 2020; 1274():29-54. PubMed ID: 32894506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective COX-2 inhibitors and dual acting anti-inflammatory drugs: critical remarks.
    Bertolini A; Ottani A; Sandrini M
    Curr Med Chem; 2002 May; 9(10):1033-43. PubMed ID: 12733982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Non-steroidal anti-inflammatory agents with selective inhibitory activity on cyclooxygenase-2. Interest and future prospects].
    Blain H; Jouzeau JY; Netter P; Jeandel C
    Rev Med Interne; 2000 Nov; 21(11):978-88. PubMed ID: 11109595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COXIBs, CINODs and H₂S-releasing NSAIDs: current perspectives in the development of safer non steroidal anti-inflammatory drugs.
    Fiorucci S; Distrutti E
    Curr Med Chem; 2011; 18(23):3494-505. PubMed ID: 21756233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of COX-2 inhibitors in common clinical practice a gastroenterologist's perspective.
    Lehmann FS; Beglinger C
    Curr Top Med Chem; 2005; 5(5):449-64. PubMed ID: 15974940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current perspective on the cardiovascular effects of coxibs.
    Konstam MA; Weir MR
    Cleve Clin J Med; 2002; 69 Suppl 1():SI47-52. PubMed ID: 12086293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclooxygenase-2-selective inhibitors: translating pharmacology into clinical utility.
    Cronstein BN
    Cleve Clin J Med; 2002; 69 Suppl 1():SI13-9. PubMed ID: 12086289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microsomal prostaglandin E2 synthase: a safer target than cyclooxygenases?
    Timmers L; Pasterkamp G; de Kleijn DP
    Mol Interv; 2007 Aug; 7(4):195-9, 180. PubMed ID: 17827439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vane's discovery of the mechanism of action of aspirin changed our understanding of its clinical pharmacology.
    Botting RM
    Pharmacol Rep; 2010; 62(3):518-25. PubMed ID: 20631416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of action of aspirin-like drugs.
    Vane JR; Botting RM
    Semin Arthritis Rheum; 1997 Jun; 26(6 Suppl 1):2-10. PubMed ID: 9219313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting inhibition of COX-2: a review of patents, 2002-2006.
    da Cunha EF; Ramalho TC; Josa D; Caetano MS; de Souza TC
    Recent Pat Inflamm Allergy Drug Discov; 2007 Jun; 1(2):108-23. PubMed ID: 19075973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclooxygenase-2 inhibition and side-effects of non-steroidal anti-inflammatory drugs in the gastrointestinal tract.
    Meyer-Kirchrath J; Schrör K
    Curr Med Chem; 2000 Nov; 7(11):1121-9. PubMed ID: 11032962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COX-2-Specific inhibitors--the emergence of a new class of analgesic and anti-inflammatory drugs.
    Everts B; Währborg P; Hedner T
    Clin Rheumatol; 2000; 19(5):331-43. PubMed ID: 11055820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of nonsteroidal antiinflammatory drugs and cyclooxygenase-2 inhibitors on experimental colitis.
    Paiotti AP; Marchi P; Miszputen SJ; Oshima CT; Franco M; Ribeiro DA
    In Vivo; 2012; 26(3):381-93. PubMed ID: 22523290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COX-2 inhibitors.
    Hawkey CJ
    Lancet; 1999 Jan; 353(9149):307-14. PubMed ID: 9929039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mechanism of action of aspirin.
    Vane JR; Botting RM
    Thromb Res; 2003 Jun; 110(5-6):255-8. PubMed ID: 14592543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.